Advertisement
Screener

NEUROPACE, INC. (NPCE) Interest Expense on Debt

2.8 / 5 stars · 68/120 Roast Me

NEUROPACE, INC. Interest Expense on Debt

NEUROPACE, INC. (NPCE) reported Interest Expense on Debt of $5.60 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpenseDebt · last filed 2022-11-08

  • NEUROPACE, INC. interest expense, debt for the quarter ending 2022-09-30 was $1.90M, a 5.56% increase year-over-year.
  • NEUROPACE, INC. interest expense, debt for the quarter ending 2021-09-30 was $1.80M.
Period endInterest Expense, Debt 3 monthInterest Expense, Debt 6 monthInterest Expense, Debt 9 month
2022-09-30$1.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$5.60M
10-Q · filed 2022-11-08
2022-06-30$3.70M
10-Q · filed 2022-08-11
2021-09-30$1.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$5.50M
10-Q · filed 2022-11-08
2021-06-30$3.70M
10-Q · filed 2022-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
CARLSMED, INC. (CARL)United States$0.405B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Orthofix Medical Inc. (OFIX)$0.373B
SS Innovations International, Inc. (SSII)$0.589B-64.06
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39